References

Iga vasculitis

10.1007/s00281-021-00874-9 · 2021 · External reference

Pathogenesis of IgA vasculitis: an up-to-date review

10.3389/fimmu.2021.771619 · 2021 · External reference

Iga vasculitis update: epidemiology, pathogenesis, and biomarkers

10.3389/fimmu.2022.921864 · 2022 · External reference

An emerging role for neutrophil extracellular traps in IgA vasculitis: a mini-review

10.3389/fimmu.2022.912929 · 2022 · External reference

New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)

10.1016/j.autrev.2017.10.009 · 2017 · External reference

NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis

10.1093/rheumatology/keaf272 · 2025 · External reference

A review of the mechanism of vascular endothelial injury in immunoglobulin A vasculitis

10.3389/fphys.2022.833954 · 2022 · External reference

Von Willebrand factor and factor XIII in children with Henoch–Schönlein purpura

10.1007/bf00860949 · 1995 · External reference

Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch–Schönlein purpura

10.1136/adc.75.6.507 · 1996 · External reference

Von Willebrand factor, factor VIII, and other acute phase reactants as biomarkers of inflammation and endothelial dysfunction in chronic graft-versus-host disease

10.3389/fimmu.2021.676756 · 2021 · External reference

Endothelial cell activation, Weibel–Palade body secretion, and enhanced angiogenesis in severe COVID-19

10.1016/j.rpth.2023.100085 · 2023 · External reference

Prolonged elevations of factor VIII and von Willebrand factor antigen after multisystem inflammatory syndrome in children

10.1097/mph.0000000000002583 · 2023 · External reference

The von Willebrand factor antigen reflects the juvenile dermatomyositis disease activity score

10.3390/biomedicines11020552 · 2023 · External reference

Von Willebrand factor antigen as a marker of disease activity in childhood-onset antineutrophil cytoplasmic antibody-associated vasculitis

10.1093/rheumatology/kead600 · 2024 · External reference

Value of the biomarker soluble tyrosine kinase 1 type fms (sFLT-1) in the diagnosis and prognosis of sepsis: a systematic review

10.1016/j.medcli.2024.03.027 · 2024 · External reference

Circulating soluble fms-like tyrosine kinase in renal diseases other than preeclampsia

10.1681/asn.2020111579 · 2021 · External reference

Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS

10.1186/s13054-021-03545-1 · 2021 · External reference

Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury

10.1186/s13054-019-2315-y · 2019 · External reference

Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch–Schönlein purpura and pediatric-onset systemic lupus erythematosus

10.1515/biol-2022-0812 · 2024 · External reference

Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol

10.1111/j.1538-7836.2006.01794.x · 2006 · External reference

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses

10.1158/1078-0432.ccr-08-0432 · 2009 · External reference

A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges

10.1038/s41598-018-24234-0 · 2018 · External reference

EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria

10.1136/ard.2009.116657 · 2010 · External reference